Deglycosylated Reduced Molecular Weight
Online Inquiry
Deglycosylated reduced molecular weight determination services for antibody drugs play a critical role in the characterization and quality control of these therapeutic molecules. Creative Proteomics provides accurate deglycosylated reduced molecular weight assays to support antibody drug development and quality control, ensuring the safety and efficacy of antibody therapeutics.
Introduction to Reduced Molecular Weight Determination
The deglycosylated reduced molecular weight assay is part of a comprehensive characterization of antibody drugs, as required by regulatory authorities. Deglycosylated reduced molecular weight assays are performed on antibody drugs to analyze changes in protein structure and molecular weight after removal of attached glycans and reduction of disulfide bonds. The glycosylation pattern and disulfide bond arrangement affect the stability, shelf life and efficacy of the drug. By determining the molecular weight of reduced antibodies that have been deglycosylated, it can help antibody drug manufacturers ensure batch-to-batch consistency and quality of their drugs.
Deglycosylated Reduced Molecular Weight Determination Methods and Procedures
Our DRMW test involves a series of well-established analytical techniques performed by our team of experienced scientists. The process typically includes:
We provide guidelines and support for the proper collection, preservation, and transportation of your antibody drug samples. Our experts ensure your samples are handled with the utmost care and according to best practices.
Glycosylated moieties are enzymatically removed from the protein backbone, leaving only the deglycosylated antibodies.
- Molecular Weight Analysis
Molecular weight determination services for antibody drugs encompass different techniques and methodologies. These methods include size exclusion chromatography (SEC), the high-resolution separation technique capillary electrophoresis (CE), and mass spectrometry (MS). Valuable information about the molecular weight and potential modifications of antibody drugs can be provided by our advanced platform technologies.
Advantages of Our Services
- Our deglycosylated reduced molecular weight assay services can be tailored to meet specific client requirements.
- Our assay services enable the detection of any changes in the molecular weight of the deglycosylated antibody. This analysis is crucial for ensuring the quality and consistency of antibody drugs during development and manufacturing processes.
- Our reduced molecular weight assay allows for the analysis of smaller fragments of the antibody. This provides a comprehensive understanding of the antibody's structure and enables us to investigate the impact of different regions on its functionality.
At Creative Proteomics, our deglycosylated reduced molecular weight assay services provide valuable insights into the impact of glycosylation and molecular weight on antibody drugs. By using these services, clients can optimize their antibody design, manufacturing processes, and ensure product quality, ultimately leading to the development of more effective and reliable antibody-based therapeutics. Contact us to learn more about deglycosylated reduced molecular weight assay service for antibody drugs. We will be happy to assist you.
